Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Zometa
Sponsor: Milton S. Hershey Medical Center
Collaborators: Novartis